1887

Journal of General Virology header logo

Volume 97, Issue 7

MCPIP1/regnase-I inhibits simian immunodeficiency virus and is not counteracted by Vpx Free

Abstract

We have previously shown that the cellular RNase MCPIP1/regnase-1 potently blocks HIV-1 infection in resting CD4 T-cells. As simian immunodeficiency virus (SIV) encodes an accessory protein named Vpx, which enhances viral replication in resting CD4 T-cells by degrading the cellular restriction factor SAMHD1, we investigated whether MCPIP1 restricts SIV infection and whether Vpx protein antagonizes MCPIP1-mediated restriction. In co-transfection studies, human MCPIP1 markedly reduced the production of infectious SIV, whereas MCPIP2 and MCPIP3 had little effect. MCPIP1 derived from cynomolgus monkey also inhibited human immunodeficiency virus (HIV-1) and SIV production, albeit to a lesser degree. Lastly, expression of SIV Vpx protein did not reduce MCPIP1 at the protein level, nor did it ablate the MCPIP1-mediated restriction. In conclusion, both human and cynomolgus monkey MCPIP1 restrict SIV replication. Unlike SAMHD1, MCPIP1-mediated HIV-1 restriction cannot be overcome by SIV Vpx.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CD4+ T cells , HIV , MCPIP1 , restriction factor and SIV
© 2016 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000482
2016-07-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/7/1693.html?itemId=/content/journal/jgv/10.1099/jgv.0.000482&mimeType=html&fmt=ahah

References

  1. Ahn J., Hao C., Yan J., DeLucia M., Mehrens J., Wang C., Gronenborn A. M., Skowronski J. 2012; HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1 . J Biol Chem 287:12550–12558 [View Article][PubMed]
     [Google Scholar]
  2. Baldauf H. M., Pan X., Erikson E., Schmidt S., Daddacha W., Burggraf M., Schenkova K., Ambiel I., Wabnitz G. et al. 2012; SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 18:1682–1687 [View Article][PubMed]
     [Google Scholar]
  3. Bergamaschi A., Ayinde D., David A., Le Rouzic E., Morel M., Collin G., Descamps D., Damond F., Brun-Vezinet F. et al. 2009; The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol 83:4854–4860 [View Article][PubMed]
     [Google Scholar]
  4. Berger A., Sommer A. F., Zwarg J., Hamdorf M., Welzel K., Esly N., Panitz S., Reuter A., Ramos I. et al. 2011; SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog 7:e1002425 [View Article][PubMed]
     [Google Scholar]
  5. Descours B., Cribier A., Chable-Bessia C., Ayinde D., Rice G., Crow Y., Yatim A., Schwartz O., Laguette N. et al. 2012; SAMHD 1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. Retrovirology 9:87 [View Article][PubMed]
     [Google Scholar]
  6. Gallois-Montbrun S., Kramer B., Swanson C. M., Byers H., Lynham S., Ward M., Malim M. H. 2007; Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J Virol 81:2165–2178 [View Article][PubMed]
     [Google Scholar]
  7. Goldstone D. C., Ennis-Adeniran V., Hedden J. J., Groom H. C., Rice G. I., Christodoulou E., Walker P. A., Kelly G., Haire L. F. et al. 2011; HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379–382 [View Article][PubMed]
     [Google Scholar]
  8. Haché G., Liddament M. T., Harris R. S. 2005; The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain. J Biol Chem 280:10920–10924 [View Article][PubMed]
     [Google Scholar]
  9. Harris R. S., Bishop K. N., Sheehy A. M., Craig H. M., Petersen-Mahrt S. K., Watt I. N., Neuberger M. S., Malim M. H. 2003; DNA deamination mediates innate immunity to retroviral infection. Cell 113:803–809 [View Article][PubMed]
     [Google Scholar]
  10. Harris R. S., Liddament M. T. 2004; Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4:868–877 [View Article][PubMed]
     [Google Scholar]
  11. Hrecka K., Hao C., Gierszewska M., Swanson S. K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M. P., Skowronski J. 2011; Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658–661 [View Article][PubMed]
     [Google Scholar]
  12. Iwasaki H., Takeuchi O., Teraguchi S., Matsushita K., Uehata T., Kuniyoshi K., Satoh T., Saitoh T., Matsushita M. et al. 2011; The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat Immunol 12:1167–1175 [View Article][PubMed]
     [Google Scholar]
  13. Jeltsch K. M., Hu D., Brenner S., Zöller J., Heinz G. A., Nagel D., Vogel K. U., Rehage N., Warth S. C. et al. 2014; Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation. Nat Immunol 15:1079–1089 [CrossRef]
     [Google Scholar]
  14. Kane M., Yadav S. S., Bitzegeio J., Kutluay S. B., Zang T., Wilson S. J., Schoggins J. W., Rice C. M., Yamashita M. et al. 2013; MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563–566 [View Article][PubMed]
     [Google Scholar]
  15. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., Yatim A., Emiliani S., Schwartz O. et al. 2011; SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654–657 [View Article][PubMed]
     [Google Scholar]
  16. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E. C., Dragin L., Bloch N., Maudet C., Bertrand M. et al. 2012; SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223–228 [View Article][PubMed]
     [Google Scholar]
  17. Li H., He H., Gong L., Fu M., Wang T. T. 2016; Preferential killing of HIV latently infected CD4+ T cells by MALT1 inhibitor. AIDS Res Hum Retroviruses 32:174–177 [View Article][PubMed]
     [Google Scholar]
  18. Liang J., Wang J., Azfer A., Song W., Tromp G., Kolattukudy P. E., Fu M. 2008; A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J Biol Chem 283:6337–6346 [View Article][PubMed]
     [Google Scholar]
  19. Liang J., Saad Y., Lei T., Wang J., Qi D., Yang Q., Kolattukudy P. E., Fu M. 2010; MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J Exp Med 207:2959–2973 [View Article][PubMed]
     [Google Scholar]
  20. Lin R. J., Chien H. L., Lin S. Y., Chang B. L., Yu H. P., Tang W. C., Lin Y. L. 2013; MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res 41:3314–3326 [View Article][PubMed]
     [Google Scholar]
  21. Liu S., Qiu C., Miao R., Zhou J., Lee A., Liu B., Lester S. N., Fu W., Zhu L. et al. 2013a; MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells. Proc Natl Acad Sci U S A 110:19083–19088 [CrossRef]
     [Google Scholar]
  22. Liu Z., Pan Q., Ding S., Qian J., Xu F., Zhou J., Cen S., Guo F., Liang C. 2013b; The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14:398–410 [View Article][PubMed]
     [Google Scholar]
  23. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. 2003; Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99–103 [View Article][PubMed]
     [Google Scholar]
  24. Matsushita K., Takeuchi O., Standley D. M., Kumagai Y., Kawagoe T., Miyake T., Satoh T., Kato H., Tsujimura T. et al. 2009; Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458:1185–1190 [View Article][PubMed]
     [Google Scholar]
  25. Neil S. J., Zang T., Bieniasz P. D. 2008; Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425–430 [View Article][PubMed]
     [Google Scholar]
  26. Nityanandam R., Serra-Moreno R. 2014; BCA2/Rabring7 targets HIV-1 Gag for lysosomal degradation in a tetherin-independent manner. PLoS Pathog 10:e1004151 [View Article][PubMed]
     [Google Scholar]
  27. Sheehy A. M., Gaddis N. C., Choi J. D., Malim M. H. 2002; Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646–650 [View Article][PubMed]
     [Google Scholar]
  28. Stremlau M., Owens C. M., Perron M. J., Kiessling M., Autissier P., Sodroski J. 2004; The cytoplasmic body component TRIM5α restricts HIV-1 infection in old world monkeys. Nature 427:848–853 [View Article][PubMed]
     [Google Scholar]
  29. Suzuki H. I., Arase M., Matsuyama H., Choi Y. L., Ueno T., Mano H., Sugimoto K., Miyazono K. 2011; MCPIP1 ribonuclease antagonizes Dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol Cell 44:424–436 [View Article][PubMed]
     [Google Scholar]
  30. Uehata T., Iwasaki H., Vandenbon A., Matsushita K., Hernandez-Cuellar E., Kuniyoshi K., Satoh T., Mino T., Suzuki Y. et al. 2013; Malt1-induced cleavage of regnase-1 in CD4+ helper T cells regulates immune activation. Cell 153:1036–1049 [View Article][PubMed]
     [Google Scholar]
  31. Wichroski M. J., Robb G. B., Rana T. M. 2006; Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog 2:e41 [View Article][PubMed]
     [Google Scholar]
  32. Zhang H., Yang B., Pomerantz R. J., Zhang C., Arunachalam S. C., Gao L. 2003; The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94–98 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000482
Loading
MCPIP1/regnase-I inhibits simian immunodeficiency virus and is not counteracted by Vpx
J. Gen. Virol. 97, 1693 (2016); https://doi.org/10.1099/jgv.0.000482
/content/journal/jgv/10.1099/jgv.0.000482
/content/journal/jgv/10.1099/jgv.0.000482
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error